手术Apgar评分改进围术期心脏风险再评估
这项在加拿大四级医院开展的回顾性队列研究纳入2009-2014年接受择期非心脏手术的16835例成人,评估手术Apgar评分(SAS)联合修订心脏风险指数(RCRI)对术后急性心肌损伤的增量预测价值。结果显示,SAS联合RCRI后区分度(c-index从0.68升至0.75)、重分类及决策曲线净获益均改善,提示术中参数可提高心脏风险再评估准确性。
要点
- SAS联合RCRI可改善非心脏手术术后急性心肌损伤的风险再评估。
- 联合模型c-index从0.68升至0.75,连续NRI为54%。
- 决策曲线分析显示所有决策阈值下净获益更高。
核心结论
- SAS与经过验证的术前风险指数联合使用时,提高了非心脏手术心脏风险评估的准确性。
研究设计与样本
- 回顾性队列研究,纳入加拿大四级医院2009-2014年接受择期非心脏手术的成人(18岁及以上)共16835例。
主要发现
- 607例(3.6%)患者发生术后急性心肌损伤。
- SAS联合RCRI的IDI为2.0%(95%CI:1.5%-2.4%),连续NRI为54%(95%CI:46%-62%)。
- c-index从0.68(95%CI:0.65-0.70)升至0.75(95%CI:0.73-0.77)。
- 决策曲线分析显示联合SAS后所有决策阈值下净获益更高。
关键数值与推荐
- SAS评分范围0-10,基于术中估计失血量、最低平均动脉压和最低心率计算。
- 主要结局为术后急性心肌损伤。
临床怎么用
- 在术前RCRI评估基础上,可结合术中SAS(失血量、最低MAP、最低心率)再评估非心脏手术患者术后心脏风险。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether the Surgical Apgar Score (SAS) improves re-estimation of perioperative cardiac risk. BACKGROUND: The SAS is a novel risk index that integrates three relevant and easily measurable intraoperative parameters (blood loss, heart rate, mean arterial pressure) to predict outcomes. The incremental prognostic value of the SAS when used in combination with standard preoperative risk indices is unclear. METHODS: We conducted a retrospective cohort study of adults (18 years and older) who underwent elective noncardiac surgery at a quaternary care hospital in Canada (2009-2014). The primary outcome was postoperative acute myocardial injury. The SAS (range 0-10) was calculated based on intraoperative estimated blood loss, lowest mean arterial pressure, and lowest heart rate documented in electronic medical records. Incremental prognostic value of the SAS when combined with the Revised Cardiac Risk Index was assessed based on discrimination (c-statistic), reclassification (integrated discrimination improvement, net reclassification index), and clinical utility (decision curve analysis). RESULTS: The cohort included 16,835 patients, of whom 607 (3.6%) patients had acute postoperative myocardial injury. Addition of the SAS to the Revised Cardiac Risk Index improved risk estimation based on the integrated discrimination improvement [2.0%; 95% confidence interval (CI): 1.5%-2.4%], continuous net reclassification index (54%; 95% CI: 46%-62%), and c-index, which increased from 0.68 (95% CI: 0.65-0.70) to 0.75 (95% CI: 0.73-0.77). On decision curve analysis, addition of the SAS to the Revised Cardiac Risk Index resulted in a higher net benefit at all decision thresholds. CONCLUSIONS: When combined with a validated preoperative risk index, the SAS improved the accuracy of cardiac risk assessment for noncardiac surgery. Further research is needed to delineate how intraoperative data can better guide postoperative decision-making.
引用
- Daza JF, Bartoszko J, Van Klei W, et al. Improved Re-estimation of Perioperative Cardiac Risk Using the Surgical Apgar Score: A Retrospective Cohort Study. Ann Surg. 2022. PMID: 35801710. doi:10.1097/SLA.0000000000005509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。